Senior Director, Adult RSV Vaccine Medical Evidence Strategy Lead
New York City, New York, United States of America
Full Time
5 hours ago
$254,100 - $423,500 USD
Visa Sponsor
Key skills
Collaboration
About this role
Role Overview
Assume a global role within the RSV adult vaccines asset with focus on medical evidence strategy.
Coordinate evidence generation work across Pfizer for adult RSV vaccine studies.
Oversee regulatory interactions related to Abrysvo vaccine effectiveness studies in adults.
Provide input on RSV adult study design and execution based on expertise in RSV disease and epidemiologic methods.
Develop common strategies across studies and study sites.
Establish relationships with external partners for collaboration.
Assist with troubleshooting major scientific/epidemiology issues during study implementation.
Requirements
MD degree with expertise in vaccinology and field-based and analytic epidemiology.
At least 10 years of experience in vaccine-related or vaccine-preventable disease related medical/scientific activities including research, clinical development, epidemiological, and immunization programs.
Recognized expert in vaccines and viral respiratory disease.
Lead or senior author of at least 5 peer-reviewed publications or book chapters.
Principal or lead investigator for at least two major projects.
Specific expertise in adult RSV epidemiology and vaccine effectiveness studies.
Proficiency with MS-Office software (Word, Excel, PowerPoint).
Fluent in English writing, reading, speaking.
Benefits
Health benefits to include medical, prescription drug, dental and vision coverage.
Paid vacation, holiday and personal days.
Paid caregiver/parental and medical leave.
401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution.